Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Pace Program

Research Leaders

7 sponsors active, led by National Institute on Aging (NIA)

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06740162Not ApplicableRecruiting

Physical Activity and Community EmPOWERment Project

NCT02381457Completed

SNP-based Microdeletion and Aneuploidy RegisTry (SMART)

Showing all 2 trials

Research Network

Common Treatments

  • Pace Program1

Active Sponsors

  • National Institute on Aging (NIA)1
  • Children's Hospital of Philadelphia1
  • University of North Carolina, Chapel Hill1
  • University of California, San Francisco1
  • George Washington University1

Top Investigators

Related Conditions

  • Praderwilli Syndrome2
  • Trisomy 13 Syndrome1
  • Fragile X Syndrome1
  • Neurodevelopmental Disorders1
  • Williams Syndrome1

Activity Timeline